GSK hails survival data with revived myeloma drug Blenrep

cafead

Administrator
Staff member
  • cafead   Nov 14, 2024 at 10:22: AM
via GSK's drive to resurrect its multiple myeloma therapy Blenrep has continued with new data from the DREAMM-7 trial showing an increase in overall survival (OS) with the drug had reached statistical significance.

article source